1-β-D-阿拉伯呋喃糖基胞嘧啶5'-金刚烷酸酯（NSC 117614）对L1210白血病小鼠的抗肿瘤作用。 - Suppr | 超能文献

Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.

作者信息

Neil G L, Wiley P F, Manak R C, Moxley T E

出版信息

Cancer Res. 1970 Apr;30(4):1047-54.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.1-β-D-阿拉伯呋喃糖基胞嘧啶5'-金刚烷酸酯（NSC 117614）对L1210白血病小鼠的抗肿瘤作用。

Cancer Res. 1970 Apr;30(4):1047-54.

2

Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.四氢尿苷对L1210白血病小鼠中1-β-D-阿拉伯呋喃糖基胞嘧啶（阿糖胞苷）口服活性的增强作用。

Cancer Res. 1970 Aug;30(8):2166-72.

3

Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.脂质体类型和给药途径在脂质体包裹的1-β-D-阿拉伯呋喃糖基胞嘧啶对小鼠L1210白血病抗肿瘤活性中的作用

Cancer Res. 1979 Apr;39(4):1390-5.

4

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。

Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.

5

N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.

Cancer Res. 1977 Aug;37(8 Pt 1):2481-6.

6

Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.

Biochem Pharmacol. 1971 Dec;20(12):3295-308. doi: 10.1016/0006-2952(71)90434-5.

7

Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.

Cancer Res. 1979 Aug;39(8):3129-33.

8

Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.用盐酸1-β-D-阿拉伯呋喃糖基胞嘧啶对小鼠白血病L1210进行化疗。I.治疗方案的影响。

Cancer Res. 1966 May;26(5):853-9.

9

Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.O-2,2'-环胞苷单乙酸酯（脱水阿糖胞苷；NSC-129220）的L1210抗白血病活性研究——关于治疗方案依赖性与阿糖胞苷（NSC-63878）的比较

Cancer Chemother Rep. 1972 Aug;56(4):483-92.

10

Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.脂质体磷脂 - N4 - 棕榈酰基和N4 - 十六烷基 - 1 - β - D - 阿拉伯呋喃糖基胞嘧啶缀合物的体内合成及构效关系研究

Anticancer Drug Des. 1996 Sep;11(6):451-62.

引用本文的文献

1

Lipid-based drug carriers for prodrugs to enhance drug delivery.用于前药以增强药物递送的脂质基药物载体。

AAPS J. 2015 Jan;17(1):83-92. doi: 10.1208/s12248-014-9670-z. Epub 2014 Oct 1.

2

Synthesis and biological evaluation of some phosphate triester derivatives of the anti-cancer drug araC.抗癌药物阿糖胞苷的一些磷酸三酯衍生物的合成与生物学评价

Nucleic Acids Res. 1989 Sep 25;17(18):7195-201. doi: 10.1093/nar/17.18.7195.